The activation of CD4+ T cell differentiation through Th1 and Th2 cells, as well as the dysfunction of Th17 cells and T regulatory cells, which affect the balance of pro- and anti-inflammation, are all potential pathways that diabetes may follow. The gene discussed is CD4; the disease is diabetes mellitus.